Three multi-investigator groups that operate principally in the TB/HIV space: The South African TB Vaccine Initiative (SATVI), which includes Mark Hatherill (Director), Tom Scriba (Deputy Director) and Elisa Nemes
Three multi-investigator groups that operate principally in the TB/HIV space: The South African TB Vaccine Initiative (SATVI), which includes Mark Hatherill (Director), Tom Scriba (Deputy Director) and Elisa Nemes
Three multi-investigator groups that operate principally in the TB/HIV space: The South African TB Vaccine Initiative (SATVI), which includes Mark Hatherill (Director), Tom Scriba (Deputy Director) and Elisa Nemes
Three multi-investigator groups that operate principally in the TB/HIV space: The South African TB Vaccine Initiative (SATVI), which includes Mark Hatherill (Director), Tom Scriba (Deputy Director) and Elisa Nemes
For information on South Africa''s response to COVID-19 please visit the COVID-19 Corona Virus South African Resource Portal.
Three multi-investigator groups that operate principally in the TB/HIV space: The South African TB Vaccine Initiative (SATVI), which includes Mark Hatherill (Director), Tom Scriba (Deputy Director) and Elisa Nemes
Three multi-investigator groups that operate principally in the TB/HIV space: The South African TB Vaccine Initiative (SATVI), which includes Mark Hatherill (Director), Tom Scriba (Deputy Director) and Elisa Nemes
For information on South Africa''s response to COVID-19 please visit the COVID-19 Corona Virus South African Resource Portal.
Three multi-investigator groups that operate principally in the TB/HIV space: The South African TB Vaccine Initiative (SATVI), which includes Mark Hatherill (Director), Tom Scriba (Deputy Director) and Elisa Nemes
For information on South Africa''s response to COVID-19 please visit the COVID-19 Corona Virus South African Resource Portal.
For information on South Africa''s response to COVID-19 please visit the COVID-19 Corona Virus South African Resource Portal.